New Issue: Science’s Impossible Questions. Read Now

FDA Overturns a 30-Year Ban on Blood Donations by Gay Men

The U.S. Food and Drug Administration says the eased restrictions are based on the latest scientific evidence

man donating blood

The agency said it has worked with other government agencies and considered input from outside advisory bodies, and has "carefully examined the most recent available scientific evidence to support the current policy revision."

©iStock

Join Our Community of Science Lovers!

The U.S. Food and Drug Administration ruled on Monday that gay men can donate blood 12 months after their last sexual contact with another man, overturning a 30-year ban aimed at preventing the transmission of HIV, the virus that causes AIDS.

The agency said people with hemophilia and related blood clotting disorders will continue to be banned from donating blood due to potential harm they could suffer from large needles. Previously they were banned due to an increased risk of transmitting HIV.

The agency said it has worked with other government agencies and considered input from outside advisory bodies, and has "carefully examined the most recent available scientific evidence to support the current policy revision."


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


The agency said it has also put in place a safety monitoring system for the blood supply which it expects to provide "critical information" to help inform future FDA blood donor policies.

"Ultimately, the 12-month deferral window is supported by the best available scientific evidence, at this point in time, relevant to the U.S. population," Dr. Peter Marks, deputy director of the FDA's biologics division, said in a statement.

Several countries, including the United Kingdom and Australia, have 12-month deferrals.

During the change in Australia from an indefinite blood donor deferral policy, essentially a ban, to a 12-month deferral, studies evaluating more than 8 million units of donated blood were performed using a national blood surveillance system, the FDA said.

"These published studies document no change in risk to the blood supply with use of the 12-month deferral," the agency said. "Similar data are not available for shorter deferral intervals."

The agency said its policies to date have helped reduce HIV transmission rates from blood transfusions from 1 in 2,500 to 1 in 1.47 million.

(Reporting by Toni Clarke in Washington; Editing by David Gregorio)

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe